Market Value1,221,329,711
Total Holdings47
File Date2024-02-07
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RYZB / RayzeBio, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ACLX / Arcellx, Inc.
UNCY / Unicycive Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ALLK / Allakos Inc.
SLNO / Soleno Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
AVDL / Avadel Pharmaceuticals plc
SVRA / Savara Inc.
ALXO / ALX Oncology Holdings Inc.
ENGN / enGene Holdings Inc.
HRMY / Harmony Biosciences Holdings, Inc.
BOLT / Bolt Biotherapeutics, Inc.
CLNN / Clene Inc.
BCAB / BioAtla, Inc.
FULC / Fulcrum Therapeutics, Inc.
AMRS / Amyris Inc
IMPL / Impel Pharmaceuticals Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
/ Apogee Therapeutics, Inc.
ICVX / Icosavax, Inc.
PHVS / Pharvaris N.V.
AADI / Aadi Bioscience, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
TRML / Tourmaline Bio, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
RZLT / Rezolute, Inc.
TERN / Terns Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
VRDN / Viridian Therapeutics, Inc.
CMPX / Compass Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
DCTH / Delcath Systems, Inc.
SERA / Sera Prognostics, Inc.
VSTM / Verastem, Inc.
COGT / Cogent Biosciences, Inc.
FIXX / Homology Medicines, Inc.
ALGS / Aligos Therapeutics, Inc.
IOBT / IO Biotech, Inc.
SVA / Sinovac Biotech, Ltd.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
DTIL / Precision BioSciences, Inc.
DYN / Dyne Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
IOVA / Iovance Biotherapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
CDXS / Codexis, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
TIL / Instil Bio, Inc.
GERN / Geron Corporation